Skip to main content
SpringerLink
Log in

bioCSL investigates cause of Fluvax's pyrogenicity

  • Non-clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. under 5 years of age

  2. sodium taurodeoxycholate

References

  1. Rockman S, et al. Role of viral RNA and lipid in the adverse events associated with the 2010 Southern Hemisphere trivalent influenza vaccine. Vaccine 32: 3869-3876, No. 30, 24 Jun 2014. Available from: URL: http://doi.org/10.1016/j.vaccine.2014.03.035.

    Article  PubMed  Google Scholar 

  2. Rockman S, et al. Evaluation of the bioactivity of influenza vaccine strains in vitro suggests that the introduction of new strains in the 2010 Southern Hemisphere Trivalent Influenza Vaccine is associated with adverse events. Vaccine 32: 3861-3868, No. 30, 24 Jun 2014. Available from: URL: http://doi.org/10.1016/j.vaccine.2014.03.032.

    Article  CAS  PubMed  Google Scholar 

  3. TGA - Therapeutic Goods Administration. BioCSL Fluvax - investigations into the cause of fevers in children under 5 years. Internet Document : 12 Jun 2014. Available from: URL: http://www.tga.gov.au/safety/alerts-medicine-biocsl-fluvax-140612.htm.

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

bioCSL investigates cause of Fluvax's pyrogenicity. Reactions Weekly 1508, 5 (2014). https://doi.org/10.1007/s40278-014-1642-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-014-1642-7

Search

Navigation